Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

White matter hyperintensities are linked to future cognitive decline in de novo Parkinson's disease patients
Mahsa Dadar, Yashar Zeighami, Yvonne Yau, et al.
NeuroImage Clinical (2018) Vol. 20, pp. 892-900
Open Access | Times Cited: 65

Showing 1-25 of 65 citing articles:

Association Between Midlife Obesity and Its Metabolic Consequences, Cerebrovascular Disease, and Cognitive Decline
Filip Morys, Mahsa Dadar, Alain Dagher
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 10, pp. e4260-e4274
Open Access | Times Cited: 105
The Neuropsychiatry of Parkinson Disease: A Perfect Storm
Daniel Weintraub, Eugenia Mamikonyan
American Journal of Geriatric Psychiatry (2019) Vol. 27, Iss. 9, pp. 998-1018
Open Access | Times Cited: 129
Sex effects on brain structure in de novo Parkinson’s disease: a multimodal neuroimaging study
Christina Tremblay, Nooshin Abbasi, Yashar Zeighami, et al.
Brain (2020) Vol. 143, Iss. 10, pp. 3052-3066
Open Access | Times Cited: 74
Neuroimaging and fluid biomarkers in Parkinson’s disease in an era of targeted interventions
Angeliki Zarkali, George E. Thomas, Henrik Zetterberg, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
The temporal relationships between white matter hyperintensities, neurodegeneration, amyloid beta, and cognition
Mahsa Dadar, Richard Camicioli, Simon Duchesne, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 53
White matter hyperintensities are associated with grey matter atrophy and cognitive decline in Alzheimer's disease and frontotemporal dementia
Mahsa Dadar, Ana Laura Manera, Simon Ducharme, et al.
Neurobiology of Aging (2021) Vol. 111, pp. 54-63
Open Access | Times Cited: 45
Obesity-Associated Neurodegeneration Pattern Mimics Alzheimer’s Disease in an Observational Cohort Study
Filip Morys, Olivier Potvin, Yashar Zeighami, et al.
Journal of Alzheimer s Disease (2022) Vol. 91, Iss. 3, pp. 1059-1071
Open Access | Times Cited: 35
The Parkinson’s Progression Markers Initiative (PPMI) Clinical - Establishing a Deeply Phenotyped PD Cohort AM 3.2 v2
Kenneth Marek
(2024)
Open Access | Times Cited: 7
HIV infection and cerebral small vessel disease are independently associated with brain atrophy and cognitive impairment
Ryan Sanford, Jeremy F. Strain, Mahsa Dadar, et al.
AIDS (2019) Vol. 33, Iss. 7, pp. 1197-1205
Open Access | Times Cited: 46
White Matter Hyperintensities Related to Parkinson's Disease Executive Function
Patricia Linortner, Colin McDaniel, Marian Shahid, et al.
Movement Disorders Clinical Practice (2020) Vol. 7, Iss. 6, pp. 629-638
Open Access | Times Cited: 44
Cognitive and motor correlates of grey and white matter pathology in Parkinson’s disease
Mahsa Dadar, Myrlene Gee, Ashfaq Shuaib, et al.
NeuroImage Clinical (2020) Vol. 27, pp. 102353-102353
Open Access | Times Cited: 43
White Matter Hyperintensities Mediate Impact of Dysautonomia on Cognition in Parkinson's Disease
Mahsa Dadar, Seyed‐Mohammad Fereshtehnejad, Yashar Zeighami, et al.
Movement Disorders Clinical Practice (2020) Vol. 7, Iss. 6, pp. 639-647
Open Access | Times Cited: 42
White matter lesions may be an early marker for age-related cognitive decline
Cassandra Morrison, Mahsa Dadar, Sylvia Villeneuve, et al.
NeuroImage Clinical (2022) Vol. 35, pp. 103096-103096
Open Access | Times Cited: 25
White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts
Mahsa Dadar, Sawsan M. Mahmoud, Maryna Zhernovaia, et al.
NeuroImage Clinical (2022) Vol. 36, pp. 103204-103204
Open Access | Times Cited: 23
The role of Apolipoprotein E4 on cognitive impairment in Parkinson’s disease and Parkinsonisms
Angenelle Eve Rosal, Sarah L. Martin, Antonio P. Strafella
Frontiers in Neuroscience (2025) Vol. 19
Open Access
White Matter Hyperintensities: Cerebral Small‐Vessel Diseases and White Matter Microstructural Impairments
Hui Huang, Wei Song, Pengyu Wang, et al.
iRadiology (2025)
Open Access
Racial and ethnic differences in white matter hypointensities: The role of vascular risk factors
Farooq Kamal, Roqaie Moqadam, Cassandra Morrison, et al.
Alzheimer s & Dementia (2025) Vol. 21, Iss. 3
Open Access
Age- and disease-related cerebral white matter changes in patients with Parkinson's disease
Laura J. de Schipper, Anne Hafkemeijer, Mark J.R.J. Bouts, et al.
Neurobiology of Aging (2019) Vol. 80, pp. 203-209
Open Access | Times Cited: 40
Assessment of a prognostic MRI biomarker in early de novo Parkinson's disease
Yashar Zeighami, Seyed‐Mohammad Fereshtehnejad, Mahsa Dadar, et al.
NeuroImage Clinical (2019) Vol. 24, pp. 101986-101986
Open Access | Times Cited: 39
Cerebral atrophy in amyotrophic lateral sclerosis parallels the pathological distribution of TDP43
Mahsa Dadar, Ana Laura Manera, Lorne Zinman, et al.
Brain Communications (2020) Vol. 2, Iss. 2
Open Access | Times Cited: 34
The influence of white matter hyperintensity on cognitive impairment in Parkinson's disease
Hailing Liu, Bin Deng, Fen Xie, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 9, pp. 1917-1934
Open Access | Times Cited: 29
White matter hyperintensities in patients with Parkinson's disease: A systematic review and meta-analysis
Asif Butt, Joseph Kamtchum‐Tatuene, Khurshid Khan, et al.
Journal of the Neurological Sciences (2021) Vol. 426, pp. 117481-117481
Closed Access | Times Cited: 27
Longitudinal White Matter Damage Evolution in Parkinson's Disease
Pietro Giuseppe Scamarcia, Federica Agosta, Edoardo Gioele Spinelli, et al.
Movement Disorders (2021) Vol. 37, Iss. 2, pp. 315-324
Closed Access | Times Cited: 27
White matter hyperintensity burden predicts cognitive but not motor decline in Parkinson's disease: results from the Ontario Neurodegenerative Diseases Research Initiative
Daniela Cristina Carvalho de Abreu, Frederico Pieruccini‐Faria, Yanina Sarquis‐Adamson, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 4, pp. 920-933
Open Access | Times Cited: 12
Structural Imaging in Parkinson’s Disease: New Developments
Stéphane Prange, Élise Météreau, Stéphane Thobois
Current Neurology and Neuroscience Reports (2019) Vol. 19, Iss. 8
Closed Access | Times Cited: 30
Page 1 - Next Page

Scroll to top